Skip to main content
. 2014 Jul 10;9:3313–3324. doi: 10.2147/IJN.S62793

Figure 7.

Figure 7

In vivo efficacy assay of GA-HRA.

Notes: Tumor growth kinetics with dosing every other day for 6 times (A); data are expressed as mean ± SD (n=5); aP<0.05, bP<0.01, and cP<0.001 versus the control, dP<0.05 and eP<0.01 versus GA solution, fP<0.05 versus combination of GA-ATRA-HA solution; relative body weight ratio of tumor-bearing mice after the treatment (B); data are expressed as mean ± SD (n=5); **P<0.01 versus control; representative images of paraffin-embedded tumor sections after TUNEL (the apoptotic cells shown in green) and HE staining (C).

Abbreviations: ATRA, all-trans retinoic acid; GA, gambogic acid; GA-HRA, GA-loaded HRA nanoparticles; HA, hyaluronic acid; HE, hematoxylin and eosin; HRA, hyaluronic acid-g-all-trans retinoic acid; SD, standard deviation; TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling.